InterCure Ltd.

InterCure Ltd.

INCR · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic

3.79USD-0.19 (-4.77%)

Price History

Full chart

Market Stats

Previous Close3.98
Open4.03
Day Range3.76 – 4.03
52-Week Range3.40 – 8.45
Volume3.00K
Market Cap78.17M
P/E (TTM)0.00
Forward P/E6.18
EPS-1.08
Dividend Yield0.00%
Beta0.59
50-Day Avg5.03
200-Day Avg4.74

About

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Alexander Rabinovich
  • Employees285
  • Headquarters85 Medinat ha-Yehudim Street, Herzliya, Israel, 4676670, USA
  • Websitehttps://www.intercure.co

Leadership

  • Mr. Alexander RabinovichFounder, CEO & Chairman · b. 1971
  • Mr. Amos CohenChief Financial Officer · b. 1979
  • Ms. Einat ZehaviChief Executive Officer of Retail
  • Mr. Omer LayaniChief Technology Officer
  • Mr. Yarin LidorHead of Marketing
  • Mr. Dean SimhonHead of Supply Chain

Financials

Income Statement

Currency: ILS2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue13.23M12.07M8.47M8.25M5.65M1.40M-008.93M65.03M219.68M388.68M355.55M238.84M270.20M
Growth (%)--8.75%-29.83%-2.59%-31.52%-75.20%----+628.60%+237.78%+76.93%-8.52%-32.82%+13.13%
Cost of Revenue3.13M2.89M2.00M1.84M1.87M538.71K-0-7.45M33.06M128.55M233.60M250.46M208.61M237.02M
Gross Profit10.10M9.18M6.47M6.41M3.78M862.71K-0-1.48M31.98M91.13M155.08M105.09M30.23M33.18M
Gross Margin76.34%76.03%76.44%77.67%66.85%61.58%---16.57%49.17%41.48%39.90%29.56%12.66%12.28%
Operating Expense15.10M10.98M8.65M8.34M6.45M3.37M-3.98M-4.89M70.38M62.94M104.46M146.66M97.44M26.45M
Operating Income-5.00M-1.80M-2.17M-1.94M-2.67M-2.51M1.20M-3.98M-10.62M-3.42M-38.40M28.19M50.63M-41.57M-67.21M6.73M
Operating Margin-37.82%-14.95%-25.67%-23.47%-47.31%-179.16%----38.26%-59.05%12.83%13.03%-11.69%-28.14%2.49%
EBITDA-3.21M544.26K45.38M-6.38M-3.77M-1.64M-1.07M-1.09M-10.12M-3.77M-34.53M31.17M70.23M-23.90M-51.31M-7.29M
EBITDA Margin-24.28%4.51%535.88%-77.28%-66.71%-117.06%----42.19%-53.09%14.19%18.07%-6.72%-21.48%-2.70%
Net Income-12.56M-6.80M43.44M-6.61M-3.79M-1.88M265.42K-5.26M-12.80M-5.89M-37.23M4.69M44.82M-61.96M-67.80M-35.71M
Net Income Margin-94.98%-56.35%512.95%-80.07%-67.13%-134.05%----66.02%-57.25%2.13%11.53%-17.43%-28.38%-13.22%
R&D1.03M844.93K351.18K104.47K50.62K----1.71M1.58M1.24M632.00K388.00K414.00K390.00K
R&D as % of Total Revenue7.78%7.00%4.15%1.27%0.90%----19.16%2.42%0.56%0.16%0.11%0.17%0.14%
Interest Expense8.81M7.08M1.83M86.69K109.00K206.89K411.59K639.51K1.03M1.97M528.00K5.04M14.69M24.22M20.64M19.66M
Interest Expense % of Total Revenue66.61%58.65%21.62%1.05%1.93%14.77%---22.09%0.81%2.30%3.78%6.81%8.64%7.28%

Balance Sheet

Currency: ILS2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-2.92M14.53M6.16M2.64M12.62M27.73M23.95M35.92M282.23M326.27M686.32M958.01M786.61M762.57M690.55M
Total Liabilities-54.64M4.69M2.25M1.94M667.52K3.67M3.27M16.26M26.03M34.16M227.13M436.53M329.55M364.90M294.19M
Total Equity--51.72M9.84M3.92M697.01K11.95M24.07M20.68M19.66M255.97M274.51M448.03M501.31M455.11M396.97M396.52M
Cash-1.16M3.61M766.15K206.38K2.71M2.80M2.12M3.42M27.34M37.89M196.22M232.59M101.14M78.32M46.47M
Total Debt-40.31M1.32M-350.45K-2.39M2.94M12.78M17.05M6.68M108.91M255.16M195.68M211.40M183.01M
Net Debt-39.14M-2.29M-766.15K144.07K-2.71M-411.59K813.29K9.36M-10.29M-31.21M-87.31M22.57M94.54M133.09M136.55M

Cash Flow

Currency: ILS2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.19M-860.16K-1.57M-3.33M-1.90M-1.69M-1.17M-921.03K-1.49M-4.01M7.80M25.02M51.27M-53.63M-66.93M16.84M
Investing Cash Flow503.81K331.12K-265.25K727.84K895.60K-9.35M-10.97M-2.26M-7.96M-38.54M-22.76M-65.21M-142.50M4.77M17.69M-1.99M
Financing Cash Flow1.77M761.20K4.30M-350.45K13.22M12.27M2.86M10.61M66.17M25.29M197.94M120.45M-82.89M26.45M-46.66M
Capital Expenditure015.22K298.88K261.19K007.69K93.00K93.00K1.00K20.84M14.03M19.74M2.62M4.38M3.55M
Free Cash Flow-3.19M-875.38K-1.86M-3.59M-1.90M-1.69M-1.18M-921.03K-1.58M-4.01M-13.04M10.99M31.52M-56.25M-71.30M13.29M
Dividends Paid----------000000
FCF to OCF100.00%101.77%119.09%107.85%100.00%100.00%100.66%100.00%106.26%100.02%-167.09%43.93%61.49%104.88%106.54%78.93%
Dividend Paid to FCF----------0.00%0.00%0.00%0.00%0.00%0.00%

Earnings

Report DateMar 31, 2020Jun 30, 2020Sep 30, 2020Mar 31, 2021May 17, 2021Aug 16, 2021Nov 14, 2021Apr 4, 2022Aug 15, 2022Nov 15, 2022Mar 31, 2023May 15, 2023Aug 31, 2023Nov 14, 2023May 23, 2024Aug 29, 2024Nov 12, 2024May 1, 2025Aug 29, 2025Nov 18, 2025
EPS Estimate----0.040.040.050.050.080.080.050.010.01-0.01-0.13-0.010.010.010.030.05
EPS Actual-2.77-0.060.090.110.040.03-0.01-0.030.090.040.050.010.03-0.01-0.04-0.01-0.01-1.580.000.00
Surprise----0.00%-25.00%-120.00%-160.00%12.50%-50.00%2.67%0.00%200.00%21.00%72.02%47.00%-229.27%-15900.00%-100.00%-100.00%
Timing---After-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hours-Pre-market-----

Key Statistics & Ratios

Market Cap78.17M
Enterprise Value127.29M
Trailing P/E0.00
Forward P/E6.18
Price / Sales0.66
Price / Book0.62
EPS-1.08
Book Value7.59
Revenue (TTM)243.12M
Gross Profit (TTM)40.61M
EBITDA-55.34M
Profit Margin-13.22%
Operating Margin0.00%
Return on Equity-9.27%
Return on Assets-5.78%
Shares Outstanding15.00M
Shares Float7.86M
Beta0.59
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
1.05%
Insiders
39.17%
Retail / Other
59.78%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    20.36K0.03%

Stock Splits

  • Aug 24, 20261:5
  • Apr 8, 2021946:4209